Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Vasogen raises C$14.4 million

Vasogen (TSE:VAS) raised C$14.4 million

Read the full 51 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE